MyoKardia to Evaluate Mavacamten as an Alternative to Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Patients

September 10, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search